Board of Directors

EXECUTIVE COMMITTEE


David Main, President & CEO, Aquinox Pharmaceuticals (Chairman)


Brad Thompson, President & CEO, Oncolytics Biotech Inc. (Past Chair)


John Helou, President, Pfizer Canada Inc. (Vice Chair)


Vince Lamanna, President, Novo Nordisk Canada Inc. (Treasurer)

Ron Keefe, President & CEO, Biovectra Inc. (Member at Large)


Andrew Casey, President & CEO - BIOTECanada (Secretary)


MEMBERS


Teresa Bitetti, President, Bristol-Myers Squibb Canada Inc.

Brian Bloom,
President, Bloom Burton & Co.

Tony Cruz
, CEO, Transition Therapeutics

Natalie Dakers, CEO, CDRD Ventures Inc.

Michel Fortin, President & CEO, Prevtec Microbia Inc.

John Haslam, General Manager, Alexion Pharmaceuticals

Kevin Leshuk, General Manager, Celgene Inc.

Mark Lievonen
, President, Sanofi Pasteur Limited

Alexander Marshall, Chairman, Bio-Industrial Innovation Centre

Gordon McCauley, President & CEO, Allon Therapeutics, Inc.

John Norman, Partner, Gowlings LLP

Felipe Pastrana, General Manager, AbbVie

Greg Penner, President & CEO, NeoVentures Biotechnology Inc.

Paul Petrelli, President and General Manager, Canada, Biogen Idec. Canada Inc.

Partnership Program

Platinum

Biogen Idec

gowlings

Genzyme

Pfizer

vwr

Gold & Silver